Arthritis Clinical Trials

Inclusion Criteria:

Patients must have either failed to achieve an ACR20 response at Weeks 12 and 14 in CDP870-027, or must have completed the entire Week 52 assessment of CDP870 027 trial.

Exclusion Criteria:

RA Disease Related:

1. A diagnosis of any other inflammatory arthritis e.g. psoriatic arthritis or ankylosing spondylitis.
2. A secondary, non-inflammatory type of arthritis (e.g. OA or fibromyalgia) that in the Investigator's opinion is symptomatic enough to interfere with evaluation of the effect of CDP870 on the patient's primary diagnosis of RA.
3. A history of an infected joint prosthesis at any time with prosthesis still in situ.

4. Concomitant medication exclusion

   • Any biological therapy.
   • Any experimental therapy, within or outside a clinical trial.